{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:04:04Z","timestamp":1792919044876,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41409-021-01364-0","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T14:48:43Z","timestamp":1623250123000},"page":"2464-2470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation"],"prefix":"10.1038","volume":"56","author":[{"given":"Stephanie","family":"Mac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-7621","authenticated-orcid":false,"given":"Jason","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-7292","authenticated-orcid":false,"given":"Haris","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukaib","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet","family":"Dadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Aldoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-5320","authenticated-orcid":false,"given":"Paul","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-9607","authenticated-orcid":false,"given":"Andrew","family":"Artz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8024-8484","authenticated-orcid":false,"given":"Karamjeet","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Pullarkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Marcucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9082-0680","authenticated-orcid":false,"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-471X","authenticated-orcid":false,"given":"Monzr M.","family":"Al Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","volume":"26","author":"A D\u2019Souza","year":"2020","unstructured":"D\u2019Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2020;26:e177\u201382.","journal-title":"Biol Blood Marrow Transplant."},{"key":"1364_CR2","first-page":"1","volume":"4","author":"MA Khan","year":"2018","unstructured":"Khan MA, Bashir Q, Chaudhry QU, Ahmed P, Satti TM, Mahmood SK. Review of haploidentical hematopoietic cell transplantation. J Glob Oncol. 2018;4:1\u201313.","journal-title":"J Glob Oncol."},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","volume":"5","author":"CG Kanakry","year":"2013","unstructured":"Kanakry CG, Ganguly S, Zahurak M, Bola\u00f1os-Meade J, Thoburn C, Perkins B, et al. Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide. Sci Transl Med. 2013;5:211ra157.","journal-title":"Sci Transl Med"},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbmt.2014.08.014","volume":"21","author":"AS Al-Homsi","year":"2015","unstructured":"Al-Homsi AS, Roy TS, Cole K, Feng Y, Duffner U. Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21:604\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1364_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","volume":"11","author":"A Ruggeri","year":"2018","unstructured":"Ruggeri A, Labopin M, Bacigalupo A, Afanasyev B, Cornelissen JJ, Elmaagacli A, et al. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. J Hematol Oncol. 2018;11:40.","journal-title":"J Hematol Oncol"},{"key":"1364_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 2009;6:638\u201347.","journal-title":"Nat Rev Clin Oncol"},{"key":"1364_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","volume":"44","author":"ME de Jonge","year":"2005","unstructured":"de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet. 2005;44:1135\u201364.","journal-title":"Clin Pharmacokinet"},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2016.07.030","volume":"100","author":"EL Matz","year":"2017","unstructured":"Matz EL, Hsieh MH. Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis. Urology. 2017;100:16\u20139.","journal-title":"Urology."},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","volume":"27","author":"ML Hensley","year":"2009","unstructured":"Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009;27:127\u201345.","journal-title":"J Clin Oncol"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1200\/JCO.1991.9.11.2016","volume":"9","author":"JD Shepherd","year":"1991","unstructured":"Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9:2016\u201320.","journal-title":"J Clin Oncol"},{"key":"1364_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000012062","volume":"57","author":"KK Ballen","year":"1999","unstructured":"Ballen KK, Becker P, Levebvre K, Emmons R, Lee K, Levy W, et al. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology. 1999;57:287\u201392.","journal-title":"Oncology."},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/17474086.2017.1318054","volume":"10","author":"A Mussetti","year":"2017","unstructured":"Mussetti A, Greco R, Peccatori J, Corradini P. Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand? Expert Rev Hematol. 2017;10:479\u201392","journal-title":"Expert Rev Hematol"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1177\/106002809502900914","volume":"29","author":"MB Haselberger","year":"1995","unstructured":"Haselberger MB, Schwinghammer TL. Efficacy of MESNA for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Ann Pharmacother. 1995;29:918\u201321.","journal-title":"Ann Pharmacother"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/bmt.2015.197","volume":"50","author":"Q Jiang","year":"2015","unstructured":"Jiang Q, Huang H, Liu Q, Sun J, Zhou H, Fan Z, et al. Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine. Bone Marrow Transplant. 2015;50:1490\u20132.","journal-title":"Bone Marrow Transplant."},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1200\/JCO.1993.11.7.1306","volume":"11","author":"JM Vose","year":"1993","unstructured":"Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol. 1993;11:1306\u201310.","journal-title":"J Clin Oncol"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","volume":"25","author":"OR Copelan","year":"2019","unstructured":"Copelan OR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, et al. Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation. Biol Blood Marrow Transplant. 2019;25:785\u201390.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/tid.12455","volume":"17","author":"A Ruggeri","year":"2015","unstructured":"Ruggeri A, Roth-Guepin G, Battipaglia G, Mamez A-C, Malard F, Gomez A, et al. Incidence and risk factors for hemorrhagic cystitis in unmainuplated haploidentical transplant recipients. Transpl Infect Dis. 2015;17:822\u201330.","journal-title":"Transpl Infect Dis"},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","volume":"115","author":"L Luznik","year":"2010","unstructured":"Luznik L, Bolanos-Meade J, Zahurak M, Chen AR, Smith BD, Brodsky R, et al. High-dose cyclophosphamide as single-agent short-course prophylaxis of graft-versus-host disease. Blood. 2010;115:3224\u201330.","journal-title":"Blood."},{"key":"1364_CR19","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/blood.V128.22.3418.3418","volume":"128","author":"N Arratibel","year":"2016","unstructured":"Arratibel N, Cabrero M, Perez E, Lopez O, Lopez LB, Martin AA, et al. Hemorrhagic cystitis in haploidentical hematopoietic stem cell transplant: retrospective study and comparison with a NON-Haploidentical DONOR Transplant Group. Blood. 2016;128:3418.","journal-title":"Blood."},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.bbmt.2018.12.441","volume":"25","author":"A Mukherjee","year":"2019","unstructured":"Mukherjee A, Milton D, Ledesma C, Olson A, Alatrash G, Anderlini P, et al. Influence of the Intensity of the allogenic conditioning regimen on the risk of hemorrhagic cystitis (HC) in patients receiving post-transplant cyclophosphamide (PT-Cy) as GVHD prophylaxis. Biol Blood Marrow Transplant. 2019;25:S147\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1364_CR21","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1182\/blood-2019-127651","volume":"134","author":"GC Seval","year":"2019","unstructured":"Seval GC, Ozturk N, Bozdag SC, Yuksel MK, Topcuoglu P, Arslan O, et al. Effect of cyclophosphamide on hemorrhagic cystitis following haploidentical related compared to matched related\/unrelated donor hematopoietic stem cell transplantation: a 7-year tertiary center analysis. Blood. 2019;134:4504.","journal-title":"Blood."},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.bbmt.2020.04.028","volume":"26","author":"M Arango","year":"2020","unstructured":"Arango M, Cardona D. Hemorrhagic cystitis after haploidentical transplanation with post-transplantation cyclophosphamide: protective effect of mesna continuous infusion. Biol Blood Marrow Transplant. 2020;26:1492\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1364_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jac\/dky158","volume":"73","author":"S Cesaro","year":"2018","unstructured":"Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H. ECIL-6 Group et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother. 2018;73:12\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"1364_CR24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","volume":"95","author":"P Silva Lde","year":"2010","unstructured":"Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica. 2010;95:1183\u201390.","journal-title":"Haematologica."},{"key":"1364_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.micinf.2012.02.002","volume":"14","author":"SM Bennett","year":"2012","unstructured":"Bennett SM, Broekema NM, Imperiale MJ. BK polyomavirus: emerging pathogen. Microbes Infect. 2012;14:672\u201383.","journal-title":"Microbes Infect."},{"key":"1364_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00277-020-03930-w","volume":"99","author":"SR Jaiswal","year":"2020","unstructured":"Jaiswal SR, Singhal P, Thatai A, Bhagwati G, Aiyer HM, Chakrabart A, et al. Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation. Ann Hematol. 2020;99:839\u201345.","journal-title":"Ann Hematol."},{"key":"1364_CR27","first-page":"235","volume":"14","author":"A Azzi","year":"1994","unstructured":"Azzi A, Fanci R, Bosi A, Ciappi S, Zakrzewska K, de Santis R, et al. Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. Bone Marrow Transplant. 1994;14:235\u201340.","journal-title":"Bone Marrow Transplant"},{"key":"1364_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.bmt.1705886","volume":"41","author":"LK Dropulic","year":"2008","unstructured":"Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008;41:11\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1364_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/tid.12066","volume":"15","author":"RJ Drew","year":"2013","unstructured":"Drew RJ, Walsh A, N\u00ed Laoi B, Conneally E, Crowley B. BK virus (BKV) plasma dynamics in patients with BKV-associated hemorrhagic cystitis following allogeneic stem cell transplantation. Transpl Infect Dis. 2013;15:276\u201382.","journal-title":"Transpl Infect Dis"},{"key":"1364_CR30","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"SR Solomon","year":"2012","unstructured":"Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK, et al. Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Biol Blood Marrow Transplant. 2012;18:1859\u201366.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1364_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1182\/bloodadvances.2019000802","volume":"4","author":"H Imlay","year":"2020","unstructured":"Imlay H, Xie H, Leisenring WM, Duke ER, Kimball LE, Huang M, et al. Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Blood Adv. 2020;4:617\u201328.","journal-title":"Blood Adv"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01364-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01364-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01364-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T09:01:56Z","timestamp":1633078916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01364-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01364-0","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}